CytoMed Therapeutics Limited Ordinary Shares (GDTC) is a publicly traded Healthcare sector company. As of July 24, 2026, GDTC trades at $0.96 with a market cap of $11.36M and a P/E ratio of 0.00. GDTC moved +13.64% today. Year to date, GDTC is -37.59%; over the trailing twelve months it is -56.44%. Its 52-week range spans $0.68 to $4.05. Rallies surfaces GDTC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CytoMed Therapeutics Limited Ordinary Shares (GDTC) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. GDTC moved +13.64% today.
| Metric | Value |
|---|---|
| Price | $0.96 |
| Market Cap | $11.36M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.05 |
| 52-Week Low | $0.68 |
| Volume | 14.87K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
GDTC analyst coverage data. Average price target: $0.00.